Return to Statistics Toolbox

Volcano Plot analysis for Study ST003364

(Analysis All analyses used)
Select one or more experimental factors for Groups 1 and 2. The members of each group should be DIFFERENT.
Group1Experimental factorGroup2
Sample source:Aortic valve tissue | Analysis method:acidified MeOH/CHCl3 extraction and targeted SRM | Extraction method:acidified MeOH/CHCl3 | Morphology:mixed | Sex:mixed | Pathology:mixed (45)
Sample source:Aortic valve tissue | Analysis method:Assessment of PA and LPA recovery rates | Extraction method:acidified MeOH/CHCl3 | Morphology:mixed | Sex:mixed | Pathology:mixed (21)
Sample source:Aortic valve tissue | Analysis method:Assessment of PA and LPA recovery rates | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed (21)
Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS10 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed (1)
Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS11 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed (1)
Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS12 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed (1)
Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS13 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed (1)
Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS14 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed (1)
Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS15 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed (1)
Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS16 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed (1)
Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS17 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed (1)
Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS18 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed (1)
Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS19 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed (1)
Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS1 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed (1)
Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS20 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed (1)
Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS21 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed (1)
Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS22 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed (1)
Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS23 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed (1)
Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS24 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed (1)
Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS25 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed (1)
Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS26 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed (1)
Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS27 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed (1)
Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS28 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed (1)
Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS29 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed (1)
Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS2 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed (1)
Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS30 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed (1)
Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS31 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed (1)
Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS32 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed (1)
Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS33 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed (1)
Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS34 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed (1)
Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS35 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed (1)
Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS36 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed (1)
Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS37 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed (1)
Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS38 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed (1)
Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS39 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed (1)
Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS3 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed (1)
Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS40 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed (1)
Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS41 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed (1)
Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS42 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed (1)
Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS43 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed (1)
Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS44 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed (1)
Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS4 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed (1)
Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS5 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed (1)
Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS6 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed (1)
Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS7 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed (1)
Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS8 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed (1)
Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS9 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed (1)
Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:acidified MeOH/CHCl3 | Morphology:BAV | Sex:female | Pathology:calcific (4)
Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:acidified MeOH/CHCl3 | Morphology:BAV | Sex:female | Pathology:fibrotic (4)
Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:acidified MeOH/CHCl3 | Morphology:BAV | Sex:female | Pathology:mildly diseased (2)
Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:acidified MeOH/CHCl3 | Morphology:BAV | Sex:male | Pathology:fibrotic (1)
Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:acidified MeOH/CHCl3 | Morphology:BAV | Sex:male | Pathology:mildly diseased (1)
Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:acidified MeOH/CHCl3 | Morphology:mixed | Sex:mixed | Pathology:mixed (21)
Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:acidified MeOH/CHCl3 | Morphology:TAV | Sex:female | Pathology:calcific (4)
Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:acidified MeOH/CHCl3 | Morphology:TAV | Sex:female | Pathology:fibrotic (4)
Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:acidified MeOH/CHCl3 | Morphology:TAV | Sex:female | Pathology:mildly diseased (4)
Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:acidified MeOH/CHCl3 | Morphology:TAV | Sex:male | Pathology:calcific (5)
Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:acidified MeOH/CHCl3 | Morphology:TAV | Sex:male | Pathology:fibrotic (5)
Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:acidified MeOH/CHCl3 | Morphology:TAV | Sex:male | Pathology:mildly diseased (5)
Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:BAV | Sex:female | Pathology:calcific (6)
Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:BAV | Sex:female | Pathology:fibrotic (8)
Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:BAV | Sex:female | Pathology:mildly diseased (4)
Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:BAV | Sex:male | Pathology:calcific (11)
Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:BAV | Sex:male | Pathology:fibrotic (10)
Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:BAV | Sex:male | Pathology:mildly diseased (4)
Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed (6)
Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:TAV | Sex:female | Pathology:calcific (9)
Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:TAV | Sex:female | Pathology:fibrotic (9)
Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:TAV | Sex:female | Pathology:mildly diseased (6)
Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:TAV | Sex:male | Pathology:calcific (9)
Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:TAV | Sex:male | Pathology:fibrotic (10)
Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:TAV | Sex:male | Pathology:mildly diseased (8)
Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids identification | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed (15)
Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:BAV | Sex:female | Pathology:calcific (6)
Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:BAV | Sex:female | Pathology:fibrotic (8)
Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:BAV | Sex:female | Pathology:mildly diseased (4)
Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:BAV | Sex:male | Pathology:calcific (11)
Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:BAV | Sex:male | Pathology:fibrotic (10)
Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:BAV | Sex:male | Pathology:mildly diseased (4)
Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed (31)
Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:TAV | Sex:female | Pathology:calcific (9)
Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:TAV | Sex:female | Pathology:fibrotic (9)
Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:TAV | Sex:female | Pathology:mildly diseased (6)
Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:TAV | Sex:male | Pathology:calcific (9)
Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:TAV | Sex:male | Pathology:fibrotic (10)
Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:TAV | Sex:male | Pathology:mildly diseased (8)
P-value cutoff:    Fold-change cutoff:    Sample normalization:
Group by metabolite classification:    Use:
Maximum # of (most significant) metabolites per class to use in pvalue group calculation:
Analysis:Combine data for all analyses?:     

  logo